Tamoxifen attenuates dialysate-induced peritoneal fibrosis by inhibiting GSK-3β/β-catenin axis activation

Peritoneal fibrosis is a severe complication arising from long-term peritoneal dialysis (PD). Tamoxifen (Tamo) has been clinically proven effective in a series of fibrotic diseases, such as PD-associated encapsulating peritoneal sclerosis (EPS), but the mechanisms underlying Tamoxifen’s protective e...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Pengpeng, Tang, Huanna, Chen, Xiaoying, Ji, Shuiyu, Jin, Wei, Zhang, Jiaming, Shen, Jia, Deng, Hao, Zhao, Xiang, Shen, Quanquan, Huang, Hongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246765/
https://www.ncbi.nlm.nih.gov/pubmed/30061174
http://dx.doi.org/10.1042/BSR20180240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246765/
https://www.ncbi.nlm.nih.gov/pubmed/30061174
http://dx.doi.org/10.1042/BSR20180240

Ejemplares similares